1. Home
  2. NSSC vs DBVT Comparison

NSSC vs DBVT Comparison

Compare NSSC & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$42.63

Market Cap

1.4B

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$23.80

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
DBVT
Founded
1969
2002
Country
United States
France
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NSSC
DBVT
Price
$42.63
$23.80
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$48.17
$31.75
AVG Volume (30 Days)
478.9K
499.7K
Earning Date
02-02-2026
10-28-2025
Dividend Yield
1.40%
N/A
EPS Growth
0.75
N/A
EPS
1.32
N/A
Revenue
$192,025,000.00
$5,502,000.00
Revenue This Year
$13.32
$1,768.71
Revenue Next Year
$9.84
$1,028.88
P/E Ratio
$32.59
N/A
Revenue Growth
2.94
N/A
52 Week Low
$19.00
$3.82
52 Week High
$48.12
$26.19

Technical Indicators

Market Signals
Indicator
NSSC
DBVT
Relative Strength Index (RSI) 58.38 59.80
Support Level $41.71 $20.25
Resistance Level $44.27 $24.96
Average True Range (ATR) 1.68 1.57
MACD 0.54 -0.12
Stochastic Oscillator 73.59 67.47

Price Performance

Historical Comparison
NSSC
DBVT

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: